Trial NCT03838848

View at ClinicalTrials.gov 
Org. Study IDs: KN046-201

Last trial update was posted on 2023-03-02

MeSH Interventions

Antibodies Carboplatin Immunoglobulins Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Stage IV Non-small Cell Lung Cancer

Stopping Reasons

Cohort A,B,C end enrollments. Cohort D and E were considered to have no significant clinical benefit at the SMC meeting and decided to terminate enrollment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID